Sideroblastic anemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 25: Line 25:
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
! colspan="12" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
! colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
Line 33: Line 32:
|-
|-
! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-  
|-  
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 1
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 1
Line 49: Line 46:
!Iron in erythroblasts
!Iron in erythroblasts
!Iron stores in bone marrow
!Iron stores in bone marrow
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 1
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3
|-
|-
|
|
|Sideroblastic anemia
|Sideroblastic anemia
|
|Pallor
|
|Weaknes
|
|
|
|
Line 67: Line 61:
|present in ring form
|present in ring form
|present
|present
|
|
|
|
|
|
|
|-
|-
Line 78: Line 67:
|Iron deficiency anemia
|Iron deficiency anemia
| style="background: #F5F5F5; padding: 5px;" |pallor
| style="background: #F5F5F5; padding: 5px;" |pallor
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Jaundice
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 91: Line 80:
|absent
|absent
|absent
|absent
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|Thalasemia
|Thalasemia
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
 
| style="background: #F5F5F5; padding: 5px;" |
[[Jaundice]]
| style="background: #F5F5F5; padding: 5px;" |
 
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |jaundice
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |irritibility
| style="background: #F5F5F5; padding: 5px;" |Hpatomegaly
| style="background: #F5F5F5; padding: 5px;" |Splenomegaly
| style="background: #F5F5F5; padding: 5px;" |Growth retardation
| style="background: #F5F5F5; padding: 5px;" |micro/hypo with targeting
| style="background: #F5F5F5; padding: 5px;" |micro/hypo with targeting
| style="background: #F5F5F5; padding: 5px;" |Normal -high
| style="background: #F5F5F5; padding: 5px;" |Normal -high
Line 111: Line 98:
|present
|present
|present
|present
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
Line 131: Line 113:
|absent
|absent
|present
|present
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
Line 148: Line 125:
|
|
| colspan="3" |
| colspan="3" |
|
|
|
|
|
|
|
|
|
Line 168: Line 140:
|
|
| colspan="3" |
| colspan="3" |
|
|
|
|
|
|
|
|
|
Line 193: Line 160:
!
!
!
!
!Imaging 1
!Imaging 2
!Imaging 3
!Histopathology
|'''Gold standard'''
|'''Gold standard'''
!Additional findings
|-
|-
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tissue iron overload
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tissue iron overload
Line 216: Line 178:
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
Line 238: Line 195:
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
Line 260: Line 212:
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|}
|}

Revision as of 17:55, 2 August 2018

Sideroblastic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sideroblastic Anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sideroblastic anemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sideroblastic anemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sideroblastic anemia differential diagnosis

CDC on Sideroblastic anemia differential diagnosis

Sideroblastic anemia differential diagnosis in the news

Blogs on Sideroblastic anemia differential diagnosis

Directions to Hospitals Treating Sideroblastic anemia

Risk calculators and risk factors for Sideroblastic anemia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nazia Fuad M.D.

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Differential Diagnosis

Sideroblastic anemia must be differentiated from other causes of microcytic hypochromic anemia: iron deficiency anemia, thalassemia, anemia of chronic disease, lead poisoning, and blood loss.

• Tissue iron overload from sideroblastic anemia may act similar to hereditary hemochromatosis with liver cirrhosis, diabetes, congestive heart failure, and cardiac arrhythmias.

  • ALA Dehydratase Deficiency Porphyria
  • Acute Myeloid Leukemia (AML)
  • Congenital Erythropoietic Porphyria
  • Hereditary Coproporphyria
  • Iron Deficiency Anemia
  • Myelodysplastic Syndrome
  • Secondary Thrombocytosis


On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].

Diseases Clinical manifestations Para-clinical findings Gold standard
Symptoms Physical examination
Lab Findings
Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Peripheral blood smear Serum iron Serum TIBC Serum ferritin

g/L

Iron in erythroblasts Iron stores in bone marrow
Sideroblastic anemia Pallor Weaknes variable Normal -high Normal 50-300 present in ring form present
Microcytic hypochromic

anemia

Iron deficiency anemia pallor Jaundice microcytic/

hypochromic

<30 > 360 <15 absent absent
Thalasemia

Jaundice

jaundice irritibility Hpatomegaly Splenomegaly Growth retardation micro/hypo with targeting Normal -high Normal 50-300 present present
Anemia of chronic disease Normal Low <300 30-200 absent present
Lead poisoning
Blood loss
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Lab 1 Lab 2 Lab 3 Gold standard
Tissue iron overload

References

Template:WH Template:WS